Literature DB >> 18674555

Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease.

Blair U Bradford1, Thomas M O'Connell, Jun Han, Oksana Kosyk, Svitlana Shymonyak, Pamela K Ross, Jason Winnike, Hiroshi Kono, Ivan Rusyn.   

Abstract

Metabolomic evaluation of urine and liver was conducted to assess the biochemical changes that occur as a result of alcohol-induced liver injury. Male C57BL/6J mice were fed an isocaloric control- or alcohol-containing liquid diet with 35% of calories from corn oil, 18% protein and 47% carbohydrate/alcohol for up to 36 days ad libitum. Alcohol treatment was initiated at 7 g/kg/day and gradually reached a final dose of 21 g/kg/day. Urine samples were collected at 22, 30 and 36 days and, in additional treatment groups, liver and serum samples were harvested at 28 days. Steatohepatitis was induced in the alcohol-fed group since a 5-fold increase in serum alanine aminotransferase activity, a 6-fold increase in liver injury score (necrosis, inflammation and steatosis) and an increase in lipid peroxidation in liver were observed. Liver and urine samples were analyzed by nuclear magnetic resonance spectroscopy and electrospray infusion/Fourier transform ion cyclotron resonance-mass spectrometry. In livers of alcohol-treated mice the following changes were noted. Hypoxia and glycolysis were activated as evidenced by elevated levels of alanine and lactate. Tyrosine, which is required for l-DOPA and dopamine as well as thyroid hormones, was elevated possibly reflecting alterations of basal metabolism by alcohol. A 4-fold increase in the prostacyclin inhibitor 7,10,13,16-docosatetraenoic acid, a molecule important for regulation of platelet formation and blood clotting, may explain why chronic drinking causes serious bleeding problems. Metabolomic analysis of the urine revealed that alcohol treatment leads to decreased excretion of taurine, a metabolite of glutathione, and an increase in lactate, n-acetylglutamine and n-acetylglycine. Changes in the latter two metabolites suggest an inhibition of the kidney enzyme aminoacylase I and may be useful as markers for alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674555      PMCID: PMC2583460          DOI: 10.1016/j.taap.2008.06.022

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  42 in total

1.  Docosatetraenoic acid in endothelial cells: formation, retroconversion to arachidonic acid, and effect on prostacyclin production.

Authors:  C J Mann; T L Kaduce; P H Figard; A A Spector
Journal:  Arch Biochem Biophys       Date:  1986-02-01       Impact factor: 4.013

2.  Comparison of acute and chronic ethanol administration on rates of ethanol elmination in the rat in vivo.

Authors:  M A Bleyman; R G Thurman
Journal:  Biochem Pharmacol       Date:  1979-07-01       Impact factor: 5.858

3.  Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver.

Authors:  N Enomoto; K Ikejima; S Yamashina; A Enomoto; T Nishiura; T Nishimura; D A Brenner; P Schemmer; B U Bradford; C A Rivera; Z Zhong; R G Thurman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-07       Impact factor: 4.052

4.  CYP2E1 is not involved in early alcohol-induced liver injury.

Authors:  H Kono; B U Bradford; M Yin; K K Sulik; D R Koop; J M Peters; F J Gonzalez; T McDonald; A Dikalova; M B Kadiiska; R P Mason; R G Thurman
Journal:  Am J Physiol       Date:  1999-12

5.  Periportal and pericentral pyridine nucleotide fluorescence from the surface of the perfused liver: evaluation of the hypothesis that chronic treatment with ethanol produces pericentral hypoxia.

Authors:  S Ji; J J Lemasters; V Christenson; R G Thurman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

6.  1H NMR-based metabolomic analysis of liver, serum, and brain following ethanol administration in rats.

Authors:  Peter C Nicholas; Daniel Kim; Fulton T Crews; Jeffrey M Macdonald
Journal:  Chem Res Toxicol       Date:  2007-12-21       Impact factor: 3.739

7.  Gas chromatographic-mass spectrometric analysis of N-acetylated amino acids: the first case of aminoacylase I deficiency.

Authors:  Erik Gerlo; Rudy Van Coster; Willy Lissens; Gerda Winckelmans; Linda De Meirleir; Ron Wevers
Journal:  Anal Chim Acta       Date:  2006-05-05       Impact factor: 6.558

8.  Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo.

Authors:  G E Arteel; Y Iimuro; M Yin; J A Raleigh; R G Thurman
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

9.  Beef fat prevents alcoholic liver disease in the rat.

Authors:  A A Nanji; C L Mendenhall; S W French
Journal:  Alcohol Clin Exp Res       Date:  1989-02       Impact factor: 3.455

Review 10.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin.

Authors:  R G Thurman
Journal:  Am J Physiol       Date:  1998-10
View more
  36 in total

1.  Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease.

Authors:  Xue Shi; Banrida Wahlang; Xiaoli Wei; Xinmin Yin; K Cameron Falkner; Russell A Prough; Seong Ho Kim; Eugene G Mueller; Craig J McClain; Matthew Cave; Xiang Zhang
Journal:  J Proteome Res       Date:  2012-06-21       Impact factor: 4.466

2.  Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders.

Authors:  Willard M Freeman; Kent E Vrana
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

Review 3.  The Hepatic Lipidome: A Gateway to Understanding the Pathogenes is of Alcohol-Induced Fatty Liver.

Authors:  Robin D Clugston; Madeleine A Gao; William S Blaner
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 4.  Circulating cytokines as biomarkers of alcohol abuse and alcoholism.

Authors:  Rajeshwara N Achur; Willard M Freeman; Kent E Vrana
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

5.  Investigation of chronic alcohol consumption in rodents via ultra-high-performance liquid chromatography-mass spectrometry based metabolite profiling.

Authors:  Helen G Gika; Cheng Ji; Georgios A Theodoridis; Filippos Michopoulos; Neil Kaplowitz; Ian D Wilson
Journal:  J Chromatogr A       Date:  2012-03-03       Impact factor: 4.759

Review 6.  Alcohol effects on hepatic lipid metabolism.

Authors:  Sookyoung Jeon; Rotonya Carr
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

7.  ¹H and ³¹P NMR lipidome of ethanol-induced fatty liver.

Authors:  Harshica Fernando; Shakuntala Kondraganti; Kamlesh K Bhopale; David E Volk; Muniasamy Neerathilingam; Bhupendra S Kaphalia; Bruce A Luxon; Paul J Boor; G A Shakeel Ansari
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

8.  Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats.

Authors:  Qi Zhang; Guang-ji Wang; Ji-ye A; Di Wu; Ling-ling Zhu; Bo Ma; Yu Du
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

9.  Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice.

Authors:  Ying Qin; Ya-ping Tian
Journal:  J Transl Med       Date:  2010-11-19       Impact factor: 5.531

Review 10.  Rodent models of alcoholic liver disease: of mice and men.

Authors:  Elizabeth Brandon-Warner; Laura W Schrum; C Max Schmidt; Iain H McKillop
Journal:  Alcohol       Date:  2012-09-07       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.